← Evidence map

ReviewRheumatology (Oxford, England)2017

Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons.

Till Uhlig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28903542